Access to Medicines Training Workshop (UAEM x SfGH)

The COVID-19 period has if anything simply revealed pre-existing global health structural inequalities. The inequity in vaccine distribution perpetuated by private pharmaceutical ownership of essential medical technologies is arguably the biggest immediate obstacle to ending COVID. We have seen with HIV how despite effective treatments being invented, usually at universities with public funding, infectious diseases can persist in regions (e.g. South Africa) unable to access these. Join the UCL UAEM campaign team (part of UCL SfGH) for a workshop on the absolute essentials of A2M (access to medicine) "activisms" and understandings.

'UAEM is uniquely positioned and committed to advocating for the integrity of universities’ public-service mandates and the prioritization of global public health benefits in academic medical research. We work to promote open-source, accessible, and affordable innovation mechanisms at every stage of the university medical R&D process, including at the traditional pressure point of licensing.' - uaem.org/our_work

Certificates available upon completion of the course. This is also a good introductory course for those who wish to get involved with the UAEM team as part of UCL SfGH's 2021/2022 commmittee.